[1]
L. I. Castro-Pastrana, R. Ghannadan, M. J. Rieder, E. Dahlke, M. Hayden, and B. Carleton, “CUTANEOUS ADVERSE DRUG REACTIONS IN CHILDREN: AN ANALYSIS OF REPORTS FROM THE CANADIAN PHARMACOGENOMICS NETWORK FOR DRUG SAFETY (CPNDS)”, J Popl Ther Clin Pharmacol, vol. 18, no. 1, Dec. 2018.